Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug ontheir research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account f...

Helping Cure Opioid Addiction with the Billion-Dollar Ibogaine Market

Psychedelics are the real deal. They can help people in need, change the world, and make a lot of money, all at the same time. The severity of the opioid crisis has been well documented and needs a solution: One that is able to reduce the both the strain on thousands impa...

Simple, Uncomplicated: Find Out What Natural Beauty is All About

(Click image to play video) 2020 has been a whirlwind year for Marianna Naturals Corp. ( MRNN , Forum ). Founded in April of 2020 by both Co-Founder & Chairwoman Heather Marianna and Co-Founder, President & CEO Joel DeBellefeuille as the company is t...

Enochian Shares Trade Up 50% upon Concluding FDA Meeting for Potential HIV Cure

Shares of Enochian Biosciences reached a new 52-week high after the company reported that it successfully completed its FDA INTERACT meeting for ENOB-HV-01, a potential cure for HIV. Gene-modified cellular and immune therapies company Enochian Biosciences Inc. (EN...

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...

Gilead Drug May Cure COVID-19 But Won’t Save the Markets

Big news out today on CNBC about Gilead drug cured all 125 people from serious COVID-19 conditions within 5 days, This is amazing to hear, stocks are popping today up 3-5% which is to be expected for this type of news but the damage to the financial markets has already been ...

Barrick Gold, Desert Gold Ventures, Triumph Gold - the gold boom has begun

The price of gold has been rising for more than a year and there is no end in sight. As long as the central banks print money to cure the problems of the Corona Pandemic, the flight from money will continue and investors will exchange paper for gold or other tangible assets. I...

Evotec, Memphasys, MorphoSys - Growth Industry Health

He who is healthy has many desires, he who is ill only one. Companies around the globe deal with diseases and special features of nature in order to treat or cure them. In addition to the widespread disease of cancer, there are also topics that are less talked about, but are a...

Biotech Firm ''Creating Innovative Solutions' for Female Health

The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...

Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results

Shares of Arbutus Biopharma traded higher after the company reported significant and continuous reduction in HBsAg in 12 chronic hepatitis B subjects using 60 mg dosage of its AB-729 drug. Clinical-stage biopharmaceutical company Arbutus Biopharma Corp. (ABUS:NASD...
1 2 3 4 5